A retrospective study evaluating safety of same-day pegfilgrastim administration and incidence of cystitis and ureteritis in patients with metastatic castration resistant prostate cancer treated with cabazitaxel ± carboplatin.

Trial Profile

A retrospective study evaluating safety of same-day pegfilgrastim administration and incidence of cystitis and ureteritis in patients with metastatic castration resistant prostate cancer treated with cabazitaxel ± carboplatin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Aug 2016

At a glance

  • Drugs Pegfilgrastim (Primary) ; Cabazitaxel; Carboplatin
  • Indications Prostate cancer
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 09 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top